ICARES Medicus, Inc. (TPEX:6612)
106.00
-0.50 (-0.47%)
Aug 15, 2025, 2:31 PM CST
ICARES Medicus Revenue
ICARES Medicus had revenue of 269.20M TWD in the quarter ending June 30, 2025, with 45.56% growth. This brings the company's revenue in the last twelve months to 1.08B, up 67.55% year-over-year. In the year 2024, ICARES Medicus had annual revenue of 859.79M with 42.01% growth.
Revenue (ttm)
1.08B
Revenue Growth
+67.55%
P/S Ratio
4.18
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.51B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 859.79M | 254.34M | 42.01% |
Dec 31, 2023 | 605.45M | 93.60M | 18.29% |
Dec 31, 2022 | 511.85M | 117.93M | 29.94% |
Dec 31, 2021 | 393.92M | 31.25M | 8.62% |
Dec 31, 2020 | 362.67M | -56.70M | -13.52% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 12.63B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lotus Pharmaceutical | 19.12B |
Oneness Biotech | 112.57M |
Lumosa Therapeutics | 37.25M |
Polaris Group | 87.67M |
Center Laboratories | 1.63B |